{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:31:53Z","timestamp":1753878713877,"version":"3.41.2"},"reference-count":52,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011542","name":"Center for Clinical and Translational Science, Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Idiopathic inflammatory myopathies, beyond inclusion body myositis (<jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content>), have demonstrated an increased risk of adverse cardiovascular outcomes, particularly myocardial infarction (<jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>). This study evaluated the risk of cardiovascular disease in <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a non\u2010concurrent cohort study utilizing the expanded Rochester Epidemiologic Project, including 50 patients with <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content>, matched 1:6 to age\u2010, sex\u2010, and calendar year\u2010matched referents without <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content>. Baseline cardiovascular risk factors were recorded. Differences in baseline covariates were adjusted by the inverse probability of treatment weighting method. Participants were followed from the index date forward to determine relative risks (<jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content>) and hazard ratios (<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>) for the development of cardiovascular outcomes including <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content>, ischemic stroke, cardiomyopathy, congestive heart failure (<jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content>), and peripheral vascular disease (<jats:styled-content style=\"fixed-case\">PVD<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>50 patients with <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content> and 294 matched population referents were included. Baseline cardiovascular risk factors were similar between groups. Aspirin use was more common (28% vs. 18%, <jats:italic>p<\/jats:italic>\u2009=\u20090.03) and statin use less common (26% vs. 38%, <jats:italic>p<\/jats:italic>\u2009=\u20090.04) in <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content> versus referents. Patients with <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content> had an increased hazard of <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> compared to referents [<jats:styled-content style=\"fixed-case\">HR<\/jats:styled-content>: 5.79, 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> (2.51, 13.36)]. The risk of <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> remained consistently elevated across all models, after accounting for potential confounders. For <jats:styled-content style=\"fixed-case\">PVD<\/jats:styled-content>, 16\/50 <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content> patients versus 16\/287 referents were excluded due to pre\u2010existing <jats:styled-content style=\"fixed-case\">PVD<\/jats:styled-content> at index (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Among remaining participants, <jats:styled-content style=\"fixed-case\">RR<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">PVD<\/jats:styled-content> was 2.38 (0.82, 6.9). <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content> was not associated with an increased risk of ischemic stroke, cardiomyopathy, or <jats:styled-content style=\"fixed-case\">CHF<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content> is associated with increased risk of <jats:styled-content style=\"fixed-case\">MI<\/jats:styled-content> compared to population referents. Heightened cardiovascular monitoring and prevention strategies are needed in <jats:styled-content style=\"fixed-case\">IBM<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ene.70177","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T09:05:47Z","timestamp":1745917547000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased Risk of Myocardial Infarction in Inclusion Body Myositis: A Non\u2010Concurrent Cohort Study"],"prefix":"10.1111","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3512-1796","authenticated-orcid":false,"given":"Grayson","family":"Beecher","sequence":"first","affiliation":[{"name":"Department of Neurology Mayo Clinic  Rochester Minnesota USA"},{"name":"Division of Neurology, Department of Medicine University of Alberta  Edmonton Alberta Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Department of Neurology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Shammas","sequence":"additional","affiliation":[{"name":"Department of Neurology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alanna M.","family":"Chamberlain","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences Mayo Clinic  Rochester Minnesota USA"},{"name":"Department of Cardiovascular Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Larson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Mandrekar","sequence":"additional","affiliation":[{"name":"Department of Neurology Mayo Clinic  Rochester Minnesota USA"},{"name":"Department of Quantitative Health Sciences Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-1236","authenticated-orcid":false,"given":"Elie","family":"Naddaf","sequence":"additional","affiliation":[{"name":"Department of Neurology Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-019-0186-x"},{"key":"e_1_2_9_3_1","first-page":"445","article-title":"Epidemiology of Sporadic Inclusion Body Myositis and Polymyositis in Olmsted County, Minnesota","volume":"35","author":"Wilson F. C.","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.43456"},{"key":"e_1_2_9_5_1","first-page":"34","article-title":"Sporadic\u2010Inclusion Body Myositis (s\u2010IBM) is Not So Prevalent in Istanbul\/Turkey: A Muscle Biopsy Based Survey","volume":"30","author":"Oflazer P. S.","year":"2011","journal-title":"Acta Myologica"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2011.01669.x"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003504"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND-160198"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012004"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26412"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2011.03.016"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab716"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5350-9"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2010.01470.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr217"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25686"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1486294"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04437.x"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089827"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22520"},{"key":"e_1_2_9_21_1","first-page":"461","article-title":"Risk of Myocardial Infarction and Ischaemic Stroke in Adults With Polymyositis and Dermatomyositis: A General Population\u2010Based Study","volume":"55","author":"Rai S. K.","year":"2015","journal-title":"Rheumatology"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12245"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.808915"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05751-2"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05237-7"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.08.012"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyx268"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.08.007"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.029"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12654"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23375"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-011-0657-6"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy708"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09724-4"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009122"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.09.037"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncprheum0092"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.12.006"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.05.024"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043430"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.13672"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12321"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab754"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-021317-121427"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01056.2010"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.411363"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5416"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89303"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04498-5"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.04.005"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.246876"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ene.70177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:01:44Z","timestamp":1748347304000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ene.70177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1111\/ene.70177"],"URL":"https:\/\/doi.org\/10.1111\/ene.70177","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"type":"print","value":"1351-5101"},{"type":"electronic","value":"1468-1331"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"2025-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70177"}}